5.21
price down icon5.62%   -0.31
pre-market  Pre-mercato:  5.05   -0.16   -3.07%
loading
Precedente Chiudi:
$5.52
Aprire:
$5.48
Volume 24 ore:
1.03M
Relative Volume:
1.05
Capitalizzazione di mercato:
$356.25M
Reddito:
-
Utile/perdita netta:
$-297.11M
Rapporto P/E:
-1.0039
EPS:
-5.19
Flusso di cassa netto:
$-216.95M
1 W Prestazione:
-2.43%
1M Prestazione:
-7.46%
6M Prestazione:
-67.92%
1 anno Prestazione:
-51.26%
Intervallo 1D:
Value
$5.15
$5.91
Intervallo di 1 settimana:
Value
$5.15
$6.18
Portata 52W:
Value
$5.15
$19.71

Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile

Name
Nome
Phathom Pharmaceuticals Inc
Name
Telefono
(877) 742-8466
Name
Indirizzo
100 CAMPUS DRIVE,, FLORHAM PARK, NJ
Name
Dipendente
112
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
PHAT's Discussions on Twitter

Confronta PHAT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PHAT
Phathom Pharmaceuticals Inc
5.21 356.25M 0 -297.11M -216.95M -5.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.31 124.11B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
684.87 74.87B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
622.61 37.83B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
243.53 31.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
111.56 26.75B 3.30B -501.07M 1.03B -2.1146

Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-14 Iniziato Cantor Fitzgerald Overweight
2024-05-03 Iniziato Stifel Buy
2024-01-05 Reiterato Needham Buy
2023-08-09 Iniziato H.C. Wainwright Buy
2023-05-11 Aggiornamento Evercore ISI In-line → Outperform
2023-03-13 Iniziato Craig Hallum Buy
2022-10-21 Iniziato Jefferies Buy
2022-05-06 Downgrade Evercore ISI Outperform → In-line
2021-05-12 Aggiornamento Goldman Sell → Neutral
2021-02-17 Iniziato BMO Capital Markets Outperform
2021-02-02 Iniziato Guggenheim Buy
2020-06-26 Downgrade Goldman Neutral → Sell
2019-11-20 Iniziato Evercore ISI Outperform
2019-11-19 Iniziato Goldman Neutral
2019-11-19 Iniziato Jefferies Buy
2019-11-19 Iniziato Needham Buy
Mostra tutto

Phathom Pharmaceuticals Inc Borsa (PHAT) Ultime notizie

pulisher
Mar 03, 2025

Phathom Pharmaceuticals stock hits 52-week low at $5.21 - Investing.com

Mar 03, 2025
pulisher
Mar 01, 2025

(PHAT) Investment Analysis and Advice - Stock Traders Daily

Mar 01, 2025
pulisher
Feb 28, 2025

Phathom Pharmaceuticals (PHAT) Expected to Announce Earnings on Thursday - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Cantor Fitzgerald Upgrades Phathom Pharmaceuticals (NASDAQ:PHAT) to Strong-Buy - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Phathom Pharmaceuticals (PHAT) Projected to Post Quarterly Earnings on Thursday - Defense World

Feb 27, 2025
pulisher
Feb 25, 2025

Phathom Pharmaceuticals to Report Fourth Quarter and Full - GlobeNewswire

Feb 25, 2025
pulisher
Feb 24, 2025

Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025 - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Phathom Pharmaceuticals to Host Conference Call on March 6, 2025, for Fourth Quarter and Full Year 2024 Financial Results - Nasdaq

Feb 24, 2025
pulisher
Feb 24, 2025

Can Phathom's VOQUEZNA Sales Drive Q4 Growth? Earnings Call Set for March 6 - StockTitan

Feb 24, 2025
pulisher
Feb 18, 2025

How to Take Advantage of moves in (PHAT) - Stock Traders Daily

Feb 18, 2025
pulisher
Feb 18, 2025

Phathom Pharmaceuticals CFO Molly Henderson sells shares worth $43,370 - MSN

Feb 18, 2025
pulisher
Feb 18, 2025

Cantor Fitzgerald Begins Coverage on Phathom Pharmaceuticals (NASDAQ:PHAT) - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

Phathom spikes as Cantor Fitzgerald bullish on IP claims - MSN

Feb 17, 2025
pulisher
Feb 16, 2025

Cantor Fitzgerald Initiates Coverage on Phathom Pharmaceuticals (NASDAQ:PHAT) - Defense World

Feb 16, 2025
pulisher
Feb 14, 2025

Phathom stock gains after Cantor bullish view (PHAT:NASDAQ) - Seeking Alpha

Feb 14, 2025
pulisher
Feb 14, 2025

symbol__ Stock Quote Price and Forecast - CNN

Feb 14, 2025
pulisher
Feb 14, 2025

Phathom Pharmaceuticals initiated at Cantor Fitzgerald on ‘significant’ upside - TipRanks

Feb 14, 2025
pulisher
Feb 14, 2025

Cantor Fitzgerald Initiates Coverage on Phathom Pharmaceuticals With Overweight Rating, $23 Price Target - Marketscreener.com

Feb 14, 2025
pulisher
Feb 10, 2025

Taking a Closer Look At Phathom Pharmaceuticals Inc (PHAT) Following Its Recent Trade - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

Phathom Pharmaceuticals (PHAT) Stock Price, News & Analysis - MarketBeat

Feb 10, 2025
pulisher
Feb 09, 2025

Stifel maintains $28 target on Phathom Pharmaceuticals stock - MSN

Feb 09, 2025
pulisher
Feb 08, 2025

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Shares Bought by Jennison Associates LLC - MarketBeat

Feb 08, 2025
pulisher
Feb 07, 2025

Stifel maintains $28 target on Phathom Pharmaceuticals stock By Investing.com - Investing.com Canada

Feb 07, 2025
pulisher
Feb 07, 2025

Phathom Pharmaceuticals Inc (PHAT) Stock: Assessing the Risk and Reward - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

The Future of Phathom Pharmaceuticals Inc: Analyzing PHAT - The InvestChronicle

Feb 07, 2025
pulisher
Feb 05, 2025

Phathom Pharmaceuticals Inc [PHAT] CFO and CBO makes an insider sale of 6,583 shares worth $43371.0. - Knox Daily

Feb 05, 2025
pulisher
Feb 04, 2025

Closing Strong: Phathom Pharmaceuticals Inc (PHAT) Ends at 5.63, Down -6.01 from Last Close - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

A stock that deserves closer examination: Phathom Pharmaceuticals Inc (PHAT) - US Post News

Feb 04, 2025
pulisher
Jan 31, 2025

PHAT stock touches 52-week low at $6.06 amid market challenges - MSN

Jan 31, 2025
pulisher
Jan 31, 2025

Further weakness as Phathom Pharmaceuticals (NASDAQ:PHAT) drops 12% this week, taking five-year losses to 81% - Simply Wall St

Jan 31, 2025
pulisher
Jan 29, 2025

Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire

Jan 29, 2025
pulisher
Jan 29, 2025

Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire Inc.

Jan 29, 2025
pulisher
Jan 29, 2025

Exclusive: Phathom's Next-Gen GI Treatments Take Center Stage at Major Biotech Conference - StockTitan

Jan 29, 2025
pulisher
Jan 27, 2025

Trading (PHAT) With Integrated Risk Controls - Stock Traders Daily

Jan 27, 2025
pulisher
Jan 26, 2025

Phathom Pharmaceuticals Stock: A Comprehensive Analysis of Recent Developments - The Digital Weekly

Jan 26, 2025
pulisher
Jan 24, 2025

Insider Selling: Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) COO Sells 7,886 Shares of Stock - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Insider Selling: Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) CFO Sells 6,583 Shares of Stock - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Insider Terrie Curran Sells 19,109 Shares - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Phathom Pharmaceuticals COO Nabulsi sells $51,956 in stock By Investing.com - Investing.com South Africa

Jan 24, 2025
pulisher
Jan 23, 2025

Phathom Pharmaceuticals COO Nabulsi sells $51,956 in stock - MSN

Jan 23, 2025
pulisher
Jan 19, 2025

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT): Are Analysts Optimistic? - Yahoo Finance

Jan 19, 2025
pulisher
Jan 17, 2025

(PHAT) Technical Pivots with Risk Controls - Stock Traders Daily

Jan 17, 2025
pulisher
Jan 15, 2025

Barclays PLC Buys 45,402 Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Jan 15, 2025
pulisher
Jan 12, 2025

Phathom Pharmaceuticals (NASDAQ:PHAT) Earns Buy Rating from Needham & Company LLC - Defense World

Jan 12, 2025

Phathom Pharmaceuticals Inc Azioni (PHAT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$310.03
price down icon 3.13%
$19.13
price down icon 7.54%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Capitalizzazione:     |  Volume (24 ore):